{
  "actions": [
    {
      "acted_at": "2022-07-20",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2022-07-20",
      "action_code": "",
      "committees": [
        "SSJU"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on the Judiciary.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s4575-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Judiciary",
      "committee_id": "SSJU"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "P000603",
      "district": null,
      "name": "Paul, Rand",
      "original_cosponsor": true,
      "sponsored_at": "2022-07-20",
      "state": "KY",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-07-20",
  "number": "4575",
  "official_title": "A bill to clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr8440-117",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Right to Try Clarification Act",
  "sponsor": {
    "bioguide_id": "B001288",
    "district": null,
    "name": "Booker, Cory A.",
    "state": "NJ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-07-20",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2022-07-20",
    "date": "2022-12-21T15:54:14Z",
    "text": "Right to Try Clarification Act\n\nThis bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances)."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Right to Try Clarification Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Right to Try Clarification Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law.",
      "type": "official"
    }
  ],
  "updated_at": "2022-12-29T18:48:40Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s4575.xml"
}